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ABSTRACT 
Microemulsions were recognized after the work of Hoar and Schulman in 1943, which revealed the use of strong surface-active agent leading to 
spontaneous emulsification; however, it was in 1959 when Schulman first used the term “microemulsion” for such emulsion syste m. 
Microemulsions are optically transparent, thermodynamically stable colloidal systems, 10–100 nm diameters that form spontaneously upon 
mixing of oil, water, and emulsifier. After its discovery in 1943 to till date, more than 1200 publications have been reported and development of 
O/W type of microemulsions has been the priority for the researchers, mostly using non-ionic surfactants. Although microemulsions seem to be 
one of the most promising candidates in pharmaceuticals because of relative ease in the formulation and distinct characteristics when 
compared to other dispersion systems, its commercial success as a drug delivery system has been very little. Much of the time after its 
discovery has been exhausted in failure to understand correct formulation requisites or confusing it with other similar systems. In the face of 
increasing the number of publication year after year, its formulation has been generally based on trial-and-error. Efficient strategies for 
excipient selection and detailed understanding of microstructures contributing to its formulation is still required which may serve as the 
foundation for attaining greater success in this field. 
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INTRODUCTION 
It may be required to formulate a drug as Oral liquids for 
new molecules as well as for existing molecules. However, it 
might not be feasible to formulate such liquid systems by 
simple solution, may be due to limiting factors such as poor 
mixability, stability issues,etc. In such cases, formulations 
like emulsions, suspensions, colloidal systems, etc. may be 
used. Formulations based on conventional colloidal 
dispersions have been been used from many years, recently 
giving way to novel version of these colloidal dispersions.1 
Microemulsion is one such novel system which is 
transparent, isotropic and thermodynamically stable liquid 
mixture. Microemulsions are usually prepared by using 
correct proportions of oil phase, aqueous phase, surfactant 
system (combination of surfactant and co-surfactant). The 
aqueous phase may contain salt(s) and/or other ingredients, 
and the "oil" may actually be a complex mixture of different 
hydrocarbons and olefins. In contrast to ordinary emulsions, 
microemulsions form upon simple mixing of the components 
and do not require the high shear conditions generally used 
in the formation of ordinary emulsions. The two basic types 
of microemulsions are direct (oil dispersed in water, o/w) 
and reversed (water dispersed in oil, w/o). 2-4 
In ternary systems such as microemulsions, where two 
immiscible phases (water and ‘oil’) are present with a 
surfactant, the surfactant molecules may form a monolayer 
at the interface between the oil and water, with the 
hydrophobic tails of the surfactant molecules dissolved in 
the oil phase and the hydrophilic head groups in the aqueous 
phase. As in the binary systems (water/surfactant or 
oil/surfactant), self-assembled structures of different types 
can be formed, ranging, for example, from (inverted) 
spherical and cylindrical micelles to lamellar phases and bi-
continuous microemulsions, which may coexist with 
predominantly oil or aqueous phases. 
In principle, microemulsions can be used to deliver drugs to 
the patients via several routes, but the topical application of 
microemulsions has gained increasing interest. The three 
main factors determining the transdermal permeation of 
drugs are the mobility of drug in the vehicle, release of drug 
from the vehicle, and permeation of drug into the skin. These 
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factors affect either the thermodynamic activity that drives 
the drug into the skin or the permeability of drug in the skin, 
particularly stratum corneum. 
Microemulsions improve the transdermal delivery of several 
drugs over the conventional topical preparations such as 
emulsions5 and gels6. Mobility of drugs in microemulsions is 
more facile7, as compared to the microemulsion with gel 
former which will increase its viscosity and further decrease 
the permeation in the skin.8 The superior transdermal flux 
from microemulsions has been shown to be mainly due to 
their high solubilization potential for lipophilic and 
hydrophilic drugs. 
This generates an increased thermodynamic activity towards 
the skin. Microemulsions may affect the permeability of drug 
in the skin. In this case, the components of microemulsions 
serve as permeation enhancers.9-11 Several compounds used 
in microemulsions have been reported to improve the 
transdermal permeation by altering the structure of the 
stratum corneum.12-14 For example, short chain alkanols are 
widely used as permeation enhancers.15 It is known that 
oleic acid, a fatty acid with one double bond in the chain 
structure, perturbs the lipid barrier in the stratum corneum 
by forming separate domains which interfere with the 
continuity of the multilamellar stratum corneum and may 
induce highly permeable pathways in the stratum corneum. 
Isopropyl myristate (IPM) is used as a permeation enhancer 
in transdermal formulations, but the mechanism of its action 
is poorly understood. Nonionic surfactants are widely used 
in topical formulations as solubilizing agents but some recent 
results indicate that they may affect also the skin barrier 
function.16 It is of interest to explore the effects of these 
components in the organized microemulsion structures. The 
aim of the present study was to investigate the potential of 
several microemulsion formulations in transdermal delivery 
of lipophilic drugs. A unique attempt was made to emulsify 
coconut oil with the help of polyoxyethylene 2-cetyl ether 
(Brij 52) and isopropanol or ethanol, forming stable isotropic 
dispersion thus paving way for use of plant and vegetable oil 
to be used as oil phase in microemulsion.17 
HISTORICAL BACKGROUND 
The combination of water and oil, made into a single-phase 
system with the aid of a third component (surfactant), was 
patented in mid 1930’s. However, it was not until 1943 when 
the first academic studies were performed.18 Hoar and 
Schulman showed, with the help of a strong surface-active 
agent, it is possible to induce spontaneous emulsification.19 
This is now attributed to microemulsion formation, owing to 
very low interfacial tensions promoted by the surfactants. 
According to Winsor (1948) there are four types of 
microemulsions: (i) Type I- biphasic with an upper excess oil 
phase and lower O/W emulsion, (ii) Type II- biphasic with an 
upper W/O emulsion and lower excess water phase, (iii) 
Type III- triphasic with upper excess oil phase, middle 
bicontinuous microemulsion and lower excess water phase, 
(iv) Type IV- monophasic, single microemulsion phase. 
Depending on the emulsifier used, microemulsions can 
transition between each type quite easily. A simple change in 
temperature, in the case of a non-ionic surfactant or salinity, 
S, in the case of an ionic surfactant can result in transition 
from a Type I → III → II microemulsion. An increase in 
surfactant concentration can also induce a transition from 
any of these microemulsion types to a Type IV 
microemulsion, within temperature or salinity constraints.18  
In 1959, Schulman et al.,19 titrated a multiphase system 
(consisting of water, oil and surfactant) with alcohol and 
obtained a transparent solution which they termed ’a 
microemulsion’. At that early stage some researchers 
preferred to identify these systems with ‘swollen micelles’20, 
others used the term ‘micellar emulsion’.21 Nevertheless, the 
term ‘microemulsion’ is a commonly used name nowadays. A 
detailed historical background of microemulsions can be 
found elsewhere. 22 
Microemulsions were confused with Nanoemulsions in the 
past, primarily due to comparable characteristics of having 
nannomter size range as well as similar preparation 
technique. A number studies have been published to 
delineate between both the systems.23 
 
 
Table 1 Summarising general differences between Nanoemulsion and Microemulsion 
Property Nanoemulsions Microemulsions 
Types Oil in Water  and Water in Oil type Type I :- Two phased, O/W type 
Type II :- Two phased, W/O type 
Type III :- Three phase system 
Type IV :- Single phase system 
Droplet Size 10 nm to 300 nm >100 nm 
Preparation Usually, High Energy methods and also Low 
Energy methods 
Low Energy Methods 
Stability Kinetically stable Thermodynamically stable 
Interfacial 
tension 
High interfacial tension Very low interfacial tension 
Micellar 
Structures 
Spherical nano-sized micelles Structures such as; spherical, continuous, hexagonal, 
cylindrical, cubic, lamellar, etc. (depending upon 
formulation variables) 
Structural 
Variations 
Do not show deformation on slight changes 
temperature and composition 
Temperature and compositional variation induces 
deformation of micellar structure 
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ADVANATGES AND DISADVANATGES OF 
MICROEMULSION BASED SYSTEMS 
Advantages:  
Microemulsions possess a number of unique characteristics 
that render them suitable for drug delivery. Unfortunately, 
their complex nature does not always make them a viable 
option for drug delivery. Understanding the key advantages 
and disadvan- tages of microemulsion drug delivery systems 
is essential in making informed decisions regarding the 
delivery of the active pharmaceutical ingredient (API) in 
question. Advantages Microemulsions are uniquely 
equipped for drug delivery. In particular, microemulsions 
are able to:  
i) administer APIs in liquid form,  
ii) improve bioavailability and stability via small droplet 
sizes,  
iii) solubilize and delivery both hydrophilic and lipophilic 
drugs,  
iv) form spontaneously with relatively simple starting 
ingredients.24 
Disadvantages  
Some factors limit the use of microemulsion in 
pharmaceutical applications. 
i) The need of pharmaceutically acceptable ingredients 
limits the choice of microemulsion components (e.g., 
oil, surfactant and cosurfactants) leading to difficulties 
in formulation. 
ii) The concentration of surfactants and co-surfactants 
used must be kept low for toxicological reasons. 
iii) Microemulsion also suffers from limitations of phase 
separation. 
iv) For intravenous use, the demand of toxicity on the 
formulation is rigorous and very few studies have been 
reported so far. 
v) The major limitation is the toxicity of excipients i.e. 
surfactant/ co-surfactants. Exploration of safe 
excipients and evaluation of the toxicity parameters of 
available excipients may help in further expansion of 
research in this field. 25 
DEVELOPMENT OF MICROEMULSIONS 
Role of Phase Diagrams: 
The microemulsion region is usually characterized by 
constructing ternary-phase diagrams. Three components are 
the basic requirement to form a microemulsion: an oil phase, 
an aqueous phase and a surfactant. If a cosurfactant is used, 
it may sometimes be represented at a fixed ratio to 
surfactant as a single component, and treated as a single 
"pseudo-component". The relative amounts of these three 
components can be represented in a ternary phase diagram. 
Gibbs phase diagrams can be used to show the influence of 
changes in the volume fractions of the different phases on 
the phase behavior of the system. 26 
The three components composing the system are each found 
at an apex of the triangle, where their corresponding volume 
fraction is 100%. Moving away from that corner reduces the 
volume fraction of that specific component and increases the 
volume fraction of one or both of the two other components. 
Each point within the triangle represents a possible 
composition of a mixture of the three components or 
pseudo-components, which may consist (ideally, according 
to the Gibbs' phase rule) of one, two or three phases. These 
points combine to form regions with boundaries between 
them, which represent the "phase behavior" of the system at 
constant temperature and pressure.27 
The Gibbs phase diagram, however, is an empirical visual 
observation of the state of the system and may, or may not 
express the true number of phases within a given 
composition. Apparently clear single phase formulations can 
still consist of multiple iso-tropic phases (e.g. the apparently 
clear heptane/AOT/water microemulsions consist multiple 
phases). Since these systems can be in equilibrium with 
other phases, many systems, especially those with high 
volume fractions of both the two immiscible phases, can be 
easily destabilized by anything that changes this equilibrium 
e.g. high or low temperature or addition of surface tension 
modifying agents.28 
However, examples of relatively stable microemulsions can 
be found. It is believed that the mechanism for removing 
acid build up in car engine oils involves low water phase 
volume, water-in-oil (w/o) microemulsions. Theoretically, 
transport of the aqueous acid droplets through the engine oil 
to micro-dispersed calcium carbonate particles in the oil 
should be most efficient when the droplets are small enough 
to transport a single hydrogen ion (the smaller the droplets, 
the greater the number of droplets, the faster the 
neutralization). Such microemulsions are probably very 
stable across a reasonably wide range of elevated 
temperatures.29 
 
Figure 1: Illustration of microemulsion region in a 
Pseudoternary Phase Diagram showing composition of 
various micellar structures above Non-microemulsion 
region. 
Three types of microemulsions are most likely to be formed 
depending on the composition: 
 Oil in water microemulsions wherein oil droplets are 
dispersed in the continuous  aqueous phase 
 Water in oil microemulsions wherein water droplets 
are dispersed in the continuous oil phase; 
 Bi-continuous microemulsions wherein micro-domains 
of oil and water are inter-dispersed within the system. 
In all three types of microemulsions, the interface is 
stabilized by an appropriate combination of the surfactants 
and/or co-surfactants. The key difference between 
emulsions and microemulsions are that the former, whilst 
they may exhibit excellent kinetic stability, are 
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fundamentally thermodynamically unstable and phases will 
eventually separate. Another important difference concerns 
their appearance; emulsions are cloudy while 
microemulsions are clear or translucent. In addition, there 
are distinct differences in their method of preparation, since 
emulsions require a large input of energy while 
microemulsions do not. The latter point has obvious 
implications when considering the relative cost of 
commercial production of the two types of system.3 
Theory of Microemulsion Formulation: 
Various theories concerning microemulsion formation, 
stability and phase behavior have been proposed over the 
years. For example, one explanation for their 
thermodynamic stability is that the oil/water dispersion is 
stabilized by the surfactant present and their formation 
involves the elastic properties of the surfactant film at the 
oil/water interface, which involves as parameters, the 
curvature and the rigidity of the film. These parameters may 
have an assumed or measured pressure and/or temperature 
dependence (and/or the salinity of the aqueous phase), 
which may be used to infer the region of stability of the 
microemulsion, or to delineate the region where three 
coexisting phases occur, for example. Calculations of the 
interfacial tension of the microemulsion with a coexisting oil 
or aqueous phase are also often of special focus and may 
sometimes be used to guide their formulation. 
Microemulsion formation and stability can be explained on 
the basis of a simplified thermodynamic rationalization. The 
free energy of microemulsion formation can be considered 
to depend on the extent to which surfactant lowers the 
surface tension of the oil–water interface and the change in 
entropy of the system such that 30, 
DGf = γDA – T DS 
Where, DG f =free energy of formation, γ = Surface tension of 
the oil–water interface DA =Change in interfacial area on 
microemulsification, DS = Change in entropy of the system 
which is effectively the dispersion entropy, and T = 
Temperature. 
It should be noted that when a microemulsion is formed, the 
change in DA is very large due to the large number of 
nanodroplets are formed. It is seen that while the value of γ 
is positive at all times, it is very small (of the order of 
fractions of mN/m), and is offset by the entropic component. 
The dominant favorable entropic contribution is the very 
large dispersion entropy arising from the mixing of one 
phase in the other in the form of large numbers of 
nanodroplets. However, favorable entropic contributions 
also arise from other dynamic processes such as surfactant 
diffusion in the interfacial layer and monomer-micelle 
surfactant exchange. 
Thus, a negative free energy of formation is achieved when 
large reductions in surface tension are accompanied by 
significant favorable entropic change. In such cases, 
microemulsification is spontaneous and the resulting 
dispersion is thermodynamically stable.Though, it has been 
know that several factors determine whether a w/o or o/w 
microemulsion system will be formed but in general it could 
be summarized that the most likely microemulsion would be 
that in which the phase with the smaller volume fraction 
forms.31 
Surfactants, co-surfactants and oil used in 
microemulsion formulation: 
 Surfactants- used to stabilize the system; -non-ionic, 
zwitter ion, cationic or anionic. 
 Co-surfactant- decrease the interfacial tension; -and 
increase the microemulsion region; -alcohols, amines, 
and cholesterol 
 Oils- hydrocarbon oils such as heptane or -cyclic oils 
like cyclohexane the droplets i.e., internal phase. 
Attempts have been made to rationalize surfactant behavior 
in terms of the hydrophilic- lipophilic balance (HLB) 32, as 
well as the critical packing parameter (CPP)29,30. Both 
approaches are fairly empirical but can be a useful guide to 
surfactant selection. The HLB takes into account the relative 
contribution of hydrophilic and hydrophobic fragments of 
the surfactant molecule. It is generally accepted that low 
HLB (3-6) surfactants are favored for the formation of w/o 
microemulsions whereas surfactants with high HLBs (8-18) 
are preferred for the formation of o/w microemulsion 
systems. Ionic surfactants such as sodium dodecyl sulphate 
which have HLBs greater than 20, often require the presence 
of a co-surfactant to reduce their effective HLB to a value 
within the range required for microemulsion formation. In 
contrast, the CPP relates the ability of surfactant to form 
particular aggregates to the geometry of the molecule itself. 
A combination of these, particularly ionic and non-ionic, can 
be very effective at increasing the extent of the 
microemulsion region. Examples of non-Ionics include 
polyoxyethylene surfactants such as Brij 35(C12E35) or sugar 
esters such as sorbitan monooleate (Span 80). Phospholipids 
are a notable example of zwitter ionic surfactants and 
exhibit excellent biocompatibility. Lecithin preparations 
from a variety of sources including soybean and egg are 
available commercially and contain 
diacylphosphatidylcholine as its major constituent.33-36 
Quaternary ammonium alkyl salts form one of the best 
known classes of cationic surfactants, with 
hexadecyltrimethyl ammonium bromide (CTAB), and the 
twin-tailed surfactant didodcecylammonium bromide 
(DDAB) are amongst the most well known. The most widely 
studied anionic surfactant is probably sodium bis-2-
ethylhexylsulphosuccinate (AOT) which is twin-tailed and is 
a particularly effective stabiliser of w/o microemulsions.37 
Table 2: Common excipients used to formulate 
Microemulsions in recent years 
Oil Phase Surfactant Co-surfactant 
Caprylic Acid Tween 80 Transcutol P 
Oleic acid Transcutol PEG 400 
Capmul MCM Cremophor RH 40 Ethanol 
Isopropyl 
Myristate 
Cremophor EL Poloxamer 407 
Capryol 90 Labrasol Propylene glycol 
  
CONCLUSION  
Although after discovery, it took time for researchers to 
understand the potential of microemulsion as a drug 
delivery system but, in recent times, a lot of studies from the 
field of pharmaceutics have targeted microemulsions. The 
number of hydrophobic, labile drugs with poor release 
characteristics have been formulated as microemulsion to 
increase solubility and bioavailability of drugs used. 
However, a considerable amount of fundamental work 
characterizing the physico-chemical behavior of 
microemulsions that needs to be performed before they can 
live up to their potential as multipurpose drug delivery 
vehicles.Recently, several research papers have been 
published for the improvement of drug delivery, but still 
there is a need to put an emphasis on its characterization 
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part including in vitro evaluation. Besides this, research 
papers shows higher percentage of surfactant (much higher 
than CMC level) used for the formation of microemulsion, 
irrespective of different routes of administration, but there 
is a lack of toxicological evaluation of the prepared 
microemulsion, which can be a broad research area in 
future. 
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